Patients with lung cancer who were Asian/Pacific Islander, Black or Hispanic experienced a higher intensity of end-of-life care compared to white patients, according to a Northwestern Medicine population-based analysis published in the Journal of Clinical Oncology.
Starving out tumor cells may be a promising therapy for treatment-resistant lung cancer, according to a study published in Science Advances.
Daily immunotherapy delivered via a dermal patch reduced risk of reactions, including anaphylaxis, in children with an immunoglobulin E (IgE)–mediated cow’s milk allergy, according to a recent clinical trial published in JAMA Pediatrics.
Postmenopausal women who took calcium and vitamin D supplements demonstrated reduced cancer mortality but increased cardiovascular mortality after a 20-year follow-up period, according to post-hoc analysis results published in Annals of Internal Medicine.
A multi-institutional team of investigators has discovered that targeting a specific protein interaction within immunosuppressive breast cancer cells may increase antitumor immune responses, according to findings published in the Journal of Clinical Investigation.
A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal of Clinical Oncology.
Women with breast cancer who carried the BRCA1 breast cancer mutation and who were enrolled in an MRI surveillance program saw an 80 percent reduction in breast cancer mortality compared to those who did not undergo MRI surveillance, according to findings published in JAMA Oncology.
A large international team led by a Northwestern Medicine investigator has established new standardized diagnostic criteria for pediatric sepsis, according to two related studies published in JAMA.
A multi-institutional team of investigators have developed a new framework for supporting healthcare providers in implementing polygenic risk score-based testing into primary care settings, according to a recent study published in Nature Medicine.
Combining multiple heart disease drugs into a single “polypill” can lower bad cholesterol and blood pressure, boost medication adherence, and reduce the risk of cardiovascular disease and death, according to a meta-analysis of recent clinical trials published in Nature Medicine.
Notifications